New AkzoNobel Site Strengthens Leading Powder Coatings Position in China

AkzoNobel has officially opened its €11 million powder coatings facility in Chengdu, western China. The new site will help to meet growing demand in the region and supply customers with a full range of powder products for the automotive, construction, furniture and IT industries.
The company now operates six powder coatings sites in the China region, while a seventh – the biggest powder coatings plant in the world – is currently being constructed in Changzhou and is due to open in October this year. AkzoNobel currently has more than 30 production sites in total across the whole of China.
“The opening of our Chengdu production site will strengthen our position as the global leader and China’s largest powder coatings supplier,” said Conrad Keijzer, AkzoNobel’s Executive Committee member responsible for Performance Coatings. “It will allow us to leverage the strong growth that we see in the western provinces of China, furthering our organic growth momentum.”
Powder coatings have a sustainability advantage in that they do not require the use of solvents. The Chengdu site is also notable from a sustainability perspective as it is the company’s first powder facility in China to use innovative technology that allows full recycling of waste water.
Investment in the new site reflects the Chinese government’s Western Development Policy, which has prompted rapid industrial growth in the region. For example, Longquanyi District – where the Chengdu plant is located – has become one of the largest car manufacturing centers in the country.
“We are going through a rapid change in western China and that is generating more demand for our business,” explained Eddie Wang, Business Director for AkzoNobel’s Powder Coatings business in North Asia. “The new Chengdu site is an important investment in the region and will enhance our support to local customers, particularly those in the automotive industry.”
Looking for chemical products? Let suppliers reach out to you!
Berger Acquisition in Industrial Paints
2026-07-16
-
Paint & Coating Industry Overview Mar.2025
This issue provides analysis of the European and German coatings markets, as well as the latest monthly reports and price trends of coatings-related chemical raw materials. Support online permanent download.Published in: Mar.2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Nippon Paint Offers $8.55 Billion for AkzoNobel’s Decorative Paints Business
-
Unable to Buy Entire AkzoNobel, Nippon Paint Begins a "Disassembled Approach"
-
AkzoNobel Rejects €12.5 Billion Offer from Nippon Paint and Sherwin-Williams, Sticks to Merger with Axalta
-
Record Net Profit, Yet “Joining Forces” with a Rival? Axalta Drops a Final Trump Card Before the Merger
-
AkzoNobel Invests €50 Million to Expand Aerospace Coatings Operations in the United States
-
AkzoNobel Completes Sale of AkzoNobel India Limited to JSW Group
-
Akzo Nobel and Axalta Announce a $25 Billion Merger Deal
-
AkzoNobel India Changes Ownership
-
AkzoNobel to Close Two European Production Sites
-
AkzoNobel and IPG Photonics Collaborate on Laser Curing Technology for Powder Coatings
Recommend Reading
-
“Fluoro-Fiasco”? Sudden Full Shutdown of Huayi Group’s Fluorochemical Plant Sends Shockwaves Through PVDF Markets
-
"Zipper-Like" Opening and Closing of Hormuz Coupled with Russian Export Ban Send Energy and Chemical Prices Soaring
-
Arkema and ENNEX Forge Global Alliance to Power the Next Generation of Safer, Smarter Battery Separators
-
Asahi Kasei Draws the Line on HMD: Strategic Exit from Hexamethylenediamine Production Signals Portfolio Refocus
-
Evonik Releases Financial Results Statement and Expects No Recovery in Global Chemical Market Demand in 2026
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
India’s Pharma Cost Problem Gets Worse
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods